The patient's temperature fell to 36'C in the first 20 hours but then fluctuated up to 38'C for five days. Further doses of quinine every 12 hours (maximum 12-2 mg/kg daily) steadily reduced the parasitaemia to zero in six days. The therapeutic concentration of plasma quinine ranged between 10-3 and 25-6 mmol/l (3 and 8 isg/ml). Six doses were given intravenously (two were only 250 mg), then 14 by mnouth for a total of 9500 mg over nine days, followed by a single dose of 75 mg pyrimethamine and 1500 mg sulfadoxine (three tablets of Fansidar). She became confused on day 7 and her haemoglobin concentration had fallen to 57 g/l by day 10. A 4 unit blood transfusion raised the.haemoglobin value to 117 g/l and rapidly restored her mental state to normal. Blood films remained negative on days 17, 24, 38, and 66.
Comment
In other reports all 11 patients treated by exchange transfusion survived, despite initial parasitaemias of between 5% and 75% (median 43%).1-4 By contrast, in a recent study the death rate was 33% (15/45 cases) in patients with cerebral malaria and parasitaemias of 0 04-33% who did not receive exchange transfusion .5 In patients with severe falciparum malaria five to 10 units of blood should be cross matched on admission and exchange transfusion considered, especially if the parasitaemia is over 10%. Intravenous quinine (or quinidine) should be started on admission in a dose of 10 mg base/kg (maximum 500 mg) given over two hours. Parasite counts and plasma concentrations of quinine at the start and end of each exchange transfusion and infusion of quinine will help determine the dose and timing of quinine. In general, quinine infusions should be given over four hours every 12-24 hours depending on renal and hepatic function. In 1980 it became evident that-she suffered lupus "flares" during her premenstrual period. Danazol was given (the first time it had been used for this indication) to try to ameliorate the premenstrual flaring. Initially, a dose of 400 mg daily was given. The clinical effect was good, the drug was well tolerated, and she went into clinical remission.
In January 1984 she complained of loose stools, churning abdominal discomfort, and a 6-75 kg loss in weight. At The dose of danazol was reduced to 100 mg and subsequently stopped. Glucagon concentrations were monitored regularly, and it appeared that after reducing the dose of danazol there was a consequent reduction in glucagon concentrations (figure), and fasting insulin concentrations returned to within the normal range.
When the drug was withdrawn glucagon concentrations dropped to within the normal range. Clinically, the patient reported that, although diarrhoea was no longer a problem (one to two times each day, normal consistency), she still had vague "butterfly" sensations in her abdomen.
To Treatment as before produced a dramatic improvement, with falls in blood pressure and serum amylase activity after three days. Computed tomography (CT) then showed a left suprarenal tumour but no abnormality in the pancreas. On 5 November she was transferred to Kobe University Hospital for further investigation.
On admission she was found to be dehydrated with a temperature of 36 9°C, pulse 84/min, and blood pressure 160/90 mm Hg. Examination elicited nothing abnormal except for diffuse tenderness in the abdomen. She had lost 9 kg in the past two years. Serum enzyme activities, including amylase, were normal but plasma catecholamine values were raised (noradrenaline 21-7 nmol/l (3670 pg/ml), adrenaline 2-6 nmol/l (470 pg/ml)). Urinary catecholamine excretion was 1030 tg/24 h (normal < 100 /Lg/24 h). CT and magnetic resonance imaging showed a left suprarenal tumour and abdominal aortography a round left adrenal tumour. Regional venous sampling showed that the serum amylase activity was 37 IU/l in the left adrenal vein and 42 IU/l in the superior vena cava, whereas the plasma catecholamine concentration was several times higher in the left adrenal vein than in other sites. After admission the blood pressure remained stable at around 140/70 mm Hg and plasma noradrenaline and adrenaline concentrations ranged from 7-2 to 16-0 nmol/l (1219 to 2705 pg/ml) and 1 1 to 2-8 nmol/l (207 to 518 pg/ml), respectively. Urinary catecholamine excretion ranged from 561 to 997
Ztg/24 h. Pancreas and biliary tract looked normal radiologically and on ultrasound assessment and salivary glands were normal clinically.
In December she had her last two episodes of symptoms with high blood pressure, provoked by upper gastrointestinal series and exercise, respectively (table). During each episode serum amylase activity was greatly increased and returned to normal within two days. In the first of these episodes urinary catecholamine excretion rose from 436 to 4320 Htg/24 h. In the second episode isoamylase analysis3 showed increased salivary type isoamylase (74 4%; normal 47-67%) and reduced pancreatic type isoamylase (14-0%; normal 35-53%). Amylase to creatinine clearance ratios in the two episodes were 5* 1% and 2 1%, respectively. Other serum enzyme activities remained normal.
A left adrenal tumour 28 X 35 X 26 cm was removed and confirmed histologically as a phaeochromocytoma. Five months later she had had no further episode of high blood pressure, and serum amylase activity was normal.
Hyperamylasaemia Urinary catecholamine excretion measured. Conversion: SI to traditional units-Noradrenaline: 1 nmol/l 169 pg/ml. Adrenaline: 1 nmol/l 183 pg/ml. ischaemia due to severe hypertension. These abnormalities in patients with severe hypertension, however, are occasionally observed in the absence of hyperamylasaemia and may not be associated with its occurrence. Why hyperamylasaemia occurs in our patient we do not know, but it was apparently related to hypertensive crisis induced by increased catecholamine secretion.
